Okayama Medical Center
In research, Okayama Medical Center stands highest in Medicine (#5,963 of 10,443 worldwide) and Health Sciences (#7,752 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 16.7× its share of world research.
- World rank, 2022–2025
- #20,991 of 28,054 · #25,119 all time
- Rank in Japan
- #617 of 1,070
- Research works
- 787 ▲ 45% vs 2013–17
- Citations
- 8.8k 11.1 per fractional work
- Top-10% rate
- 6.0% record average 16.5%
- Open access
- 52% world 28%
What is Okayama Medical Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,963 of 10,443 | 5.2% | 123 | #6337 | |
| Health SciencesDomain | #7,752 of 11,982 | 5.2% | 126 | #8498 |
Each strip is that field’s whole ranked pool, with the notch where Okayama Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Okayama Medical Center specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 16.7× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 35.7 works17×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.6×. Every wedge is a field page.
- Medicine 4.6×
- Veterinary 3.7×
- Immunology and Microbiology 0.8×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Nursing 0.6×
- Neuroscience 0.6×
- Dentistry 0.5×
- Health Professions 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Psychology 0.2×
- Chemistry 0.1×
- Physics and Astronomy 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Business, Management and Accounting 0.0×
- Economics, Econometrics and Finance 0.0×
- Materials Science 0.0×
- Social Sciences 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Okayama Medical Center?
Ranked on the composite score, Hiromi Matsubara, Masaji Seki and Aiko Ogawa lead among researchers whose main affiliation is Okayama Medical Center.
- 1 Hiromi Matsubara Japan · #211,187 worldwide 121 citations · 63 works
- 2 Masaji Seki Japan · #419,929 worldwide 55 citations · 25 works
- 3 Aiko Ogawa Japan · #487,073 worldwide 54 citations · 40 works
- 4 Sauvage Lr Japan · #528,518 worldwide 47 citations · 18 works
- 5 Makoto Takeuchi Japan · #583,477 worldwide 77 citations · 37 works
- 6 T Sezaki Japan · #634,901 worldwide 20 citations · 18 works
- 7 Ryo Soda Japan · #660,224 worldwide 9 citations · 18 works
- 8 Akihito Takeuchi Japan · #754,822 worldwide 17 citations · 19 works
- 9 Kazutaka Sunami Japan · #803,677 worldwide 54 citations · 31 works
- 10 Hiroto Shimokawahara Japan · #823,054 worldwide 12 citations · 20 works
Which keywords describe research at Okayama Medical Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment Guidelines, Echocardiography, Pulmonary Hypertension, Endothelial Dysfunction, Chronic Kidney Disease, Right Heart Assessment, Survival Prediction and Diagnosis.
- Genomic Profiling
- Tumor Staging
- PET Imaging
- Pulmonary Alveolar Microlithiasis
- Tumor Microenvironment
- Idiopathic Pulmonary Fibrosis
- Surgical Management
- Surgery
- Interstitial Lung Disease
- Complications
- Radiotherapy
- Tracheostomy
- Tissue Engineering
- Genetics
- Management
- Treatment
- Survival Prediction
- Chronic Kidney Disease
- Pulmonary Hypertension
- Echocardiography
- Treatment Guidelines
- Epidemiology
- Endothelial Dysfunction
- Right Heart Assessment
- Diagnosis
- Chemotherapy
- Immunotherapy
- Mechanical Ventilation
- Airway Stenosis
- Prognostic Factors
- Genetic Mutations
- Fibrosis
- TGF-ß
- Epithelial-Mesenchymal Transition
- Heart Failure
- Myofibroblast
- Adjuvant Therapy
- Pulmonary Sclerosing Hemangioma
- Targeted Therapy
- Embolization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Treatment Guidelines14▲ 46×4 topics
- Echocardiography13▲ 35×6 topics
- Epidemiology13▲ 2.4×52 topics
- Pulmonary Hypertension13▲ 65×3 topics
- Endothelial Dysfunction12▲ 36×5 topics
- Chronic Kidney Disease11▲ 34×6 topics
- Right Heart Assessment11▲ 195×1 topic
- Survival Prediction11▲ 195×1 topic
- Diagnosis9▲ 6.8×23 topics
- Treatment8▲ 4.6×22 topics
- Chemotherapy6▲ 6.6×16 topics
- Management6▲ 5.7×17 topics
- Immunotherapy6▲ 6.2×15 topics
- Genetics5▲ 5.5×7 topics
- Mechanical Ventilation5▲ 34×2 topics
- Tissue Engineering5▲ 6.0×2 topics
- Airway Stenosis5▲ 64×1 topic
- Tracheostomy5▲ 64×1 topic
- Prognostic Factors5▲ 7.5×14 topics
- Radiotherapy5▲ 8.5×7 topics
- Genetic Mutations4▲ 7.3×16 topics
- Complications4▲ 6.1×13 topics
- Fibrosis4▲ 15×6 topics
- Interstitial Lung Disease4▲ 45×2 topics
- TGF-ß4▲ 18×4 topics
- Surgery4▲ 7.7×8 topics
- Epithelial-Mesenchymal Transition4▲ 28×2 topics
- Surgical Management4▲ 6.2×15 topics
- Heart Failure4▲ 5.8×9 topics
- Idiopathic Pulmonary Fibrosis4▲ 55×1 topic
- Myofibroblast4▲ 55×1 topic
- Tumor Microenvironment4▲ 5.7×7 topics
- Adjuvant Therapy3▲ 17×2 topics
- Pulmonary Alveolar Microlithiasis3▲ 82×1 topic
- Pulmonary Sclerosing Hemangioma3▲ 82×1 topic
- PET Imaging3▲ 12×4 topics
- Targeted Therapy3▲ 9.0×5 topics
- Tumor Staging3▲ 18×2 topics
- Embolization3▲ 29×4 topics
- Genomic Profiling3▲ 19×2 topics
Which research topics does Okayama Medical Center publish most on?
By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Tracheal and airway disorders, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Medical Imaging and Pathology Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 11 works
- 2 Tracheal and airway disorders Pulmonary and Respiratory Medicine 5 works
- 3 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 4 works
- 4 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 3 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 6 Vascular Anomalies and Treatments Genetics 2 works
- 7 Esophageal and GI Pathology Surgery 2 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 9 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 2 works
- 10 Venous Thromboembolism Diagnosis and Management Internal Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Okayama Medical Center's research output changed?
Output in 2018–2022 was 45% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Okayama
- Okayama University
- Okayama University of Science
- Okayama University Hospital
- Sakakibara Hospital
- Industrial Technology Center of Okayama Prefecture
- Okayama Prefecture
- Hayashibara (Japan)
- Shujitsu University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.